(Stroke. 1995;26:52-56.)
© 1995 American Heart Association, Inc.
Articles |
Platelet Activation in the Cerebral Circulation in Different Subtypes of Ischemic Stroke and Binswanger's Disease
From the Department of Geriatric Medicine, Tokyo (Japan) Medical College Hospital.
Correspondence to Toshihiko Iwamoto, MD, Department of Geriatric Medicine, Tokyo Medical College Hospital, 6-7-1, Nishishinjuku, Shinjuku-ku, Tokyo, 160, Japan.
Background and Purpose The sites of platelet activation in ischemic stroke are still unclear because previous reports have not identified them and various factors accompanied by stroke can activate platelets. We therefore examined the sites of platelet activation in patients with various types of ischemic stroke.
Methods The ratio of the plasma concentration of ß-thromboglobulin (BTG) in the internal jugular vein to that in the antecubital vein (BTG-B) was calculated as an indicator of platelet activation in the cerebral circulation. Plasma BTG concentration was determined in 75 control subjects and in 186 patients with various subtypes of ischemic stroke including lacunar, atherothrombotic, and cardioembolic strokes, transient ischemic attacks, and Binswanger's disease. The BTG ratio was evaluated with regard to subtype of stroke, time of blood sampling, size of infarct, presence of vascular lesions, and the effect of ticlopidine administration.
Results The mean BTG ratio was increased even in the chronic phase of most subtypes of stroke with the exception of cardioembolic stroke, which exhibited a persistent elevation of BTG-B concentrations. Patients with Binswanger's disease showed a significant (P<.01) and frequent elevation of BTG ratio. High BTG ratios occurred in cases with vascular lesions observed on cerebral angiography. There was no correlation between the BTG ratio and infarct size. Use of ticlopidine was partially associated with a lower BTG ratio.
Conclusions Platelets were activated in the cerebral circulation of patients with stroke even in the chronic phase, which suggests the development of underlying vascular lesions and of thrombogenesis with or without infarction. Platelets were activated mainly within the heart in cases of cardioembolic stroke. An enhanced release reaction secondary to platelet activation was often seen in patients with Binswanger's disease, which indicates that its pathophysiology differs from that of other subtypes of stroke.
Key Words: Binswanger's disease • cerebral infarction • leukoencephalopathy • platelet activation
This article has been cited by other articles:
 |
|
 |
|
  H. Ay, E. M. Arsava, J. Rosand, K. L. Furie, A. B. Singhal, P. W. Schaefer, O. Wu, R. G. Gonzalez, W. J. Koroshetz, and A. G. Sorensen Severity of Leukoaraiosis and Susceptibility to Infarct Growth in Acute Stroke Stroke, May 1, 2008; 39(5): 1409 - 1413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Aono, T. Ohkubo, M. Kikuya, A. Hara, T. Kondo, T. Obara, H. Metoki, R. Inoue, K. Asayama, Y. Shintani, et al. Plasma Fibrinogen, Ambulatory Blood Pressure, and Silent Cerebrovascular Lesions: The Ohasama Study Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 963 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Mathew, H. M. Rinder, B. R. Smith, M. F. Newman, and C. S. Rinder Transcerebral Platelet Activation After Aortic Cross-Clamp Release is Linked to Neurocognitive Decline. Ann. Thorac. Surg., May 1, 2006; 81(5): 1644 - 1649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Karakantza, A. Maniatis, C. I. Metallinos, T. Papapetropoulos, C. Paschalis, A. J. Grau, L. Marquardt, and A. Ruf In Vivo Platelet Activation in Ischemic Stroke Patients * Response Stroke, October 1, 2003; 34 (10): e174 - e175. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hassan, B. J. Hunt, M. O'Sullivan, K. Parmar, J. M. Bamford, D. Briley, M. M. Brown, D. J. Thomas, and H. S. Markus Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis Brain, February 1, 2003; 126(2): 424 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tomimoto, I. Akiguchi, R. Ohtani, H. Yagi, M. Kanda, H. Shibasaki, and Y. Yamamoto The Coagulation-Fibrinolysis System in Patients With Leukoaraiosis and Binswanger Disease Arch Neurol, October 1, 2001; 58(10): 1620 - 1625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. I. Baker, J. Eikelboom, E. Lofthouse, N. Staples, V. Afshar-Kharghan, J. A. Lopez, Y. Shen, M. C. Berndt, and G. Hankey Platelet glycoprotein Ib{alpha} Kozak polymorphism is associated with an increased risk of ischemic stroke Blood, July 1, 2001; 98(1): 36 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Roman New Insight Into Binswanger Disease Arch Neurol, September 1, 1999; 56(9): 1061 - 1062. [Full Text] [PDF]
|
|
|
|
|
|
H. Tomimoto, I. Akiguchi, H. Wakita, A. Osaki, M. Hayashi, and Y. Yamamoto Coagulation Activation in Patients With Binswanger Disease Arch Neurol, September 1, 1999; 56(9): 1104 - 1108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M Smith, R. Pathansali, and P. M. Bath Platelets and stroke Vascular Medicine, August 1, 1999; 4(3): 165 - 172. [Abstract] [PDF]
|
|
|
|
 |
|
 M. T. Littleton-Kearney, P. D. Hurn, T. S. Kickler, and R. J. Traystman Incomplete global cerebral ischemia alters platelet biology in neonatal and adult sheep Am J Physiol Heart Circ Physiol, April 1, 1998; 274(4): H1293 - H1300. [Abstract] [Full Text] [PDF]
|
|